Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial

OBJECTIVE: The primary objective of the study was to explore safety and tolerability of hyperimmune caprine serum (AIMSPRO) in established diffuse cutaneous systemic sclerosis (SSc). Secondary objectives included assessment of potential efficacy and biological activity and exploration of candidate b...

Descripción completa

Detalles Bibliográficos
Autores principales: Quillinan, N P, McIntosh, D, Vernes, J, Haq, S, Denton, C P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888595/
https://www.ncbi.nlm.nih.gov/pubmed/24067785
http://dx.doi.org/10.1136/annrheumdis-2013-203674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888595/
https://www.ncbi.nlm.nih.gov/pubmed/24067785
http://dx.doi.org/10.1136/annrheumdis-2013-203674

Ejemplares similares